Michael R. Shurin, MD, PhD, D(ABMLI)
- Professor, Department of Pathology
- Professor, Department of Immunology
- Medical Director, Division of Clinical Immunopathology
Education & Training
- PhD in Immunopharmacology, Institute for Pharmacology, Acad Med Sci, Moscow (Russia), 1991
- MD, Second Moscow Medical School (Russia), 1984
Dr. Shurin's research program focuses on the mechanisms of cellular interactions within the tumor immunoenvironment. Specifically, the main topic of current research is how malignant cells regulate the immunomodulatory activity of neurons and neuroglial cells in vitro and in vivo in different cancers.
Shurin MR, Shurin GV, Zlotnikov SB and Bunimovich YL. 2020. The neuro-immune axis in the tumor microenvironment. J Immunol. 204: 280-285.
Shurin MR. 2018. Osteopontin controls immunosuppression in the tumor microenvironment. J Clin Invest. 128: 5209-5212.
Zhou Y, Shurin GV, Zhong H, Bunimovich Y, Han B and Shurin MR. 2018. Schwann cells augment cell spreading and metastasis of lung cancer. Cancer Res. 78: 5927–5939.
Bunimovich YL, Keskinov AA, Shurin GV and Shurin MR. 2017. Schwann cells: a new player in the tumor microenvironment. Cancer Immunol Immunother. 66: 959-968.
Shurin MR. 2013. Dual role of immunomodulation by anticancer chemotherapy. Nature Med. 19: 20-22.